|
SELB | Cartesian Therapeutics, Inc. |
|
|
SELB | Cartesian Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.26 |
| Leverage | 109.62% |
| Market Cap | $ 136.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -47.7m |
| Margin | -3401.27% |